Home/Hedge Fund Intelligence/Nektar Therapeutics
Nasdaq: NKTRStockForm 13F30 Jun 2026

Hedge funds that hold Nektar Therapeutics New Nasdaq: NKTR

New · CUSIP 640268306 · who reports it, how much, and how much it matters to them

34 of the 720 hedge fund managers we track reported shares of Nektar Therapeutics (Nasdaq: NKTR) on Form 13F for 30 June 2026. Between them they reported USD 402m. The largest position belongs to Two Sigma Investments, at USD 84m. The manager with the most riding on it is 22NW, where it is 18.7% of the reported book.

Managers reporting it34of 720 we track
Value they reportUSD 402mshares only, 30 Jun 2026
Funds they run355with a file on PPLI.com
Largest positionUSD 84mTwo Sigma Investments
Typical weight0.1%median share of a manager's book
Heaviest weight18.7%22NW

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

34 managers, USD 402m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Nektar Therapeutics, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Two Sigma Investments35 funds on PPLI.comUSD 84m0.1%
2Armistice Capital1 fund on PPLI.comUSD 51m0.6%
3Millennium Management6 funds on PPLI.comUSD 33m0.0%
4Braidwell12 funds on PPLI.comUSD 33m1.2%
5Sofinnova Investments1 fund on PPLI.comUSD 33m1.7%
6Orbimed Advisors1 fund on PPLI.comUSD 32m0.6%
7Dafna Capital Management6 funds on PPLI.comUSD 22m4.2%
8Deep Track Capital1 fund on PPLI.comUSD 21m0.3%
922NW1 fund on PPLI.comUSD 20m18.7%
10Bronte Capital Management Pty3 funds on PPLI.comUSD 14m1.5%
11Great Point Partners2 funds on PPLI.comUSD 12m2.3%
12Citadel Advisors32 funds on PPLI.comUSD 11m0.0%
13LMR Partners2 funds on PPLI.comUSD 7m0.0%
14Exoduspoint Capital Management7 funds on PPLI.comUSD 4.1m0.0%
15Landscape Capital Management4 funds on PPLI.comUSD 2.9m0.2%
16Voleon Capital Management13 funds on PPLI.comUSD 2.9m0.1%
17Anson Funds Management8 funds on PPLI.comUSD 2.8m0.2%
18Atom Investors1 fund on PPLI.comUSD 2.8m0.3%
19Burkehill Global Management5 funds on PPLI.comUSD 2.8m0.1%
20Exome Asset Management2 funds on PPLI.comUSD 1.6m1.0%
21Brevan Howard Capital Management39 funds on PPLI.comUSD 1.5m0.0%
22Awm Investment Company6 funds on PPLI.comUSD 1.5m0.1%
23Engineers Gate Manager1 fund on PPLI.comUSD 1.3m0.0%
24Diametric Capital2 funds on PPLI.comUSD 1.1m0.1%
25HighVista Strategies27 funds on PPLI.comUSD 608,0000.1%
26Persistent Asset Partners10 funds on PPLI.comUSD 522,0000.2%
27Rangeley Capital6 funds on PPLI.comUSD 489,0000.4%
28Capstone Investment Advisors25 funds on PPLI.comUSD 482,0000.0%
29Squarepoint Ops7 funds on PPLI.comUSD 405,0000.0%
30Marshall Wace LLP84 funds on PPLI.comUSD 230,0000.0%
31The Quarry1 fund on PPLI.comUSD 227,0000.0%
32Bayforest Capital1 fund on PPLI.comUSD 158,0000.1%
33Freestone Grove Partners1 fund on PPLI.comUSD 155,0000.0%
34Elequin Capital2 funds on PPLI.comUSD 3,9090.0%
Next: where it matters most
Where it matters most

For 22NW it is 18.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
122NWUSD 20m18.7%
2Dafna Capital ManagementUSD 22m4.2%
3Great Point PartnersUSD 12m2.3%
4Sofinnova InvestmentsUSD 33m1.7%
5Bronte Capital Management PtyUSD 14m1.5%
6BraidwellUSD 33m1.2%
7Exome Asset ManagementUSD 1.6m1.0%
8Armistice CapitalUSD 51m0.6%
9Orbimed AdvisorsUSD 32m0.6%
10Rangeley CapitalUSD 489,0000.4%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Nektar Therapeutics

What is the ticker symbol of Nektar Therapeutics?

Nektar Therapeutics trades under the symbol NKTR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 640268306.

Which hedge funds own Nektar Therapeutics (Nasdaq: NKTR)?

34 of the 720 hedge fund managers PPLI.com tracks reported Nektar Therapeutics shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 84m), Armistice Capital (USD 51m), Millennium Management (USD 33m), Braidwell (USD 33m) and Sofinnova Investments (USD 33m).

How many hedge funds hold Nektar Therapeutics?

34 managers in our coverage reported it, and between them they run 355 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Nektar Therapeutics?

22NW, where the position was 18.7% of the reported 13F book at 30 June 2026.

Does this show who is short Nektar Therapeutics?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Nektar Therapeutics or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.